Results 51 to 60 of about 428,885 (246)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Retrospective Analysis of Liver Disease: Pattern and Associated Risk Factors among Patients Admitted to a Tertiary Care Hospital in Sana’a City, Yemen [PDF]

Zagazig University Medical Journal
Background: Liver disease is a major global health burden with diverse etiologies and serious complications. Therefore, this study aimed to identify the most common types of liver disease and associated risk factors in Yemen and describe their clinical ...
Abdulqahar Al-Hattami, Abdulkareem Albathali, Abdulaleem Alkhulaidi, Taha Farhan, Kamal Yousef, Abdulrahman Khamis, Abdulfatah Alshargabi, Essam Alsafadi, Ahmed Hudna   +8 more
doaj   +1 more source

Pathogens and autoimmune hepatitis [PDF]

Clinical and Experimental Immunology, 2018
Summary Autoimmune hepatitis (AIH) is a severe form of hepatitis resulting in the autoimmune-mediated destruction of the liver parenchyma. Whereas many of the immunopathogenic events have been elucidated and some of the drivers of the disease have been identified, little is known about the aetiology of the disease. There are certain risk
U, Christen, E, Hintermann
openaire   +2 more sources

Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. [PDF]

, 2019
BACKGROUND AND AIMS Chronic hepatitis C virus (HCV) infection is associated with a wide range of immunopathological manifestations, which are significantly improved by successful interferon-based treatment.
Silvestri, T., Di Bartolomeo, Claudia, Cerny, A., Grondona, A.G., Tesei, C., Deleonardi, G., Grondona, Ana Gabriela, Semmo, N., Cerny, Andreas, Mertens, Joachim, Terziroli Beretta-Piccoli, Benedetta, Moradpour, Darius, Vergani, D., Mieli-Vergani, G., Silvestri, Tania, Muratori, Luigi, Moradpour, D., Tesei, Cinzia, Semela, D., Muratori, L., Melidona, L., Mieli-Vergani, Giorgina, Terziroli Beretta-Piccoli, B., Swiss Hepatitis C Cohort Study, Mertens, J., Semela, David, Semmo, Nasser, Vergani, Diego, Di Bartolomeo, C., Deleonardi, Gaia, Melidona, Laura   +30 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Coxiella burnetii as a possible cause of autoimmune liver disease: a case report

Journal of Medical Case Reports, 2009
Introduction Q fever is a zoonotic infection that may cause severe hepatitis. Q-fever hepatitis has not yet been associated with autoimmune hepatitis and/or primary biliary cirrhosis.
Kaech Chloe, Pache Isabelle, Raoult Didier, Greub Gilbert   +3 more
doaj   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui, Jiayang Zhan, Wei Li, Tao Jin, Dan He, Daishi Tian, Zhijun Li, Jing Lin, Yue Li, Hongyu Zhou, Bitao Bu   +10 more
wiley   +1 more source

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.

, 1997
Inherited mutations of the Fas/Apo1/CD95 gene, a cell-surface receptor involved in cell death signaling and in the control of self-reactivity, characterize the recently identified autoimmune lymphoproliferative syndromes. A patient with type 2 autoimmune
NISINI R, VAJRO P, ALMERIGHI C, IANNI A, COSTANZO A, NATOLI G, IORIO, RAFFAELE, LEVRERO M. FASAPO MUTATIONS AND AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME IN A. PATIENT WITH TYPE AUTOIMMUNE H.E.P.A.T.I.T.I.S. GASTROENTEROLOGY, VEGNENTE A, BALSANO C, ACCAPEZZATO D, PENSATI L   +11 more
core   +1 more source

Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing [PDF]

, 1988
Krämer A, Herth D, von Keyserlingk H, et al. Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing. Klinische Wochenschrift.
Sommer, D., Ludwig, W. D., Hampl, Hartmut, Riecken, Ernst-Otto, Krämer, Alexander ; https://orcid.org/, Hahn, E. G., von Keyserlingk, H., Herth, D.   +7 more
core   +1 more source